Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/34523
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChaiwat Kraiwattanapongen_US
dc.contributor.authorSupaporn Wechmongkolgornen_US
dc.contributor.authorBangon Chatriyanuyoken_US
dc.contributor.authorPatarawan Woratanaraten_US
dc.contributor.authorUmaporn Udomsubpayakulen_US
dc.contributor.authorPongsathorn Chanplakornen_US
dc.contributor.authorGun Keorochanaen_US
dc.contributor.authorWiwat Wajanavisiten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-11-09T02:48:35Z-
dc.date.available2018-11-09T02:48:35Z-
dc.date.issued2014-01-01en_US
dc.identifier.citationAsian Spine Journal. Vol.8, No.2 (2014), 119-128en_US
dc.identifier.issn19767846en_US
dc.identifier.issn19761902en_US
dc.identifier.other2-s2.0-84898777535en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84898777535&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/34523-
dc.description.abstractStudy Design: A prospective cohort. Purpose: To report the short and long term outcomes of fluoroscopically guided lumbar transforaminal epidural steroid injection (TFESI) in degenerative lumbar spondylolisthesis (DLS) patients. Overview of Literature TFESI has been widely used for the treatment of lumbosacral radicular pains. However, to our knowledge, there has been no study which has evaluated the outcomes of TFESI in patients with DLS. Methods: The DLS patients received fluoroscopically guided lumbar TFESI with 80 mg of methylprednisolone and 2 mL of 1% lidocaine hydrochloride. Patients were evaluated by an independent observer before the initial injection, at 2 weeks, at 6 weeks, at 3 months, and at 12 months after the injections. Visual analog scale (VAS), Roland 5-point pain scale, standing tolerance, walking tolerance, and patient satisfaction scale were evaluated for outcomes. Results: Thirty three DLS patients treated with TFESI, who were completely followed up, were included in this study. The average number of injections per patient was 1.9 (range from 1 to 3 injections per patient). Significant improvements in VAS and Roland 5-point pain scale were observed over the follow up period from 2 weeks to 12 months. However, the standing and walking tolerance were not significantly improved after 2 weeks. At 2 weeks, the patient satisfaction scale was highest, although, these outcomes declined with time. The DLS patients with one level of spinal stenosis showed significantly better outcome than the DLS patients with two levels of spinal stenosis. Five patients (13%) underwent surgical treatment during the 3 to 12 months follow up. Conclusions: TFESI provides short term improvements in VAS and Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale in DLS patients. In the long term, it improves VAS but limits the improvements in Roland 5-point pain scale, standing tolerance, walking tolerance and patient satisfaction scale. © 2014 by Korean Society of Spine Surgery.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84898777535&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleOutcomes of fluoroscopically guided lumbar transforaminal epidural steroid injections in degenerative lumbar spondylolisthesis patientsen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.4184/asj.2014.8.2.119en_US
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.